Eli Lilly and Co. has gained roughly 63% this year, outperforming the S & P 500 Pharmaceuticals index by over 40%. The strong outperformance from LLY has been associated with strong underperformance by other high-profile stocks within the industry group. They may be ready to catch up, according to the charts. Bristol-Myers Squibb Co. , Johnson & Johnson , and Pfizer Inc. are three examples of pharmaceutical stocks that have been out of favor. All three have cyclical downtrends in place.
All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY .
Click here for the full disclaimer.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »